Beacon Pointe Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,188
| Closed | -$203K | – | 1255 |
|
|
2025
Q1 | $203K | Buy |
3,188
+4
| +0.1% | +$255 | ﹤0.01% | 1130 |
|
|
2024
Q4 | $387K | Sell |
3,184
-8
| -0.3% | -$973 | ﹤0.01% | 904 |
|
|
2024
Q3 | $399K | Sell |
3,192
-808
| -20% | -$101K | ﹤0.01% | 916 |
|
|
2024
Q2 | $632K | Sell |
4,000
-22
| -0.5% | -$3.48K | 0.01% | 792 |
|
|
2024
Q1 | $521K | Sell |
4,022
-2,282
| -36% | -$295K | 0.01% | 893 |
|
|
2023
Q4 | $608K | Sell |
6,304
-463
| -7% | -$44.6K | 0.01% | 821 |
|
|
2023
Q3 | $820K | Sell |
6,767
-348
| -5% | -$42.2K | 0.01% | 688 |
|
|
2023
Q2 | $815K | Sell |
7,115
-338
| -5% | -$38.7K | 0.01% | 570 |
|
|
2023
Q1 | $1.03M | Sell |
7,453
-2,580
| -26% | -$356K | 0.02% | 538 |
|
|
2022
Q4 | $1.3M | Sell |
10,033
-492
| -5% | -$63.8K | 0.03% | 450 |
|
|
2022
Q3 | $1.16M | Buy |
10,525
+210
| +2% | +$23.2K | 0.03% | 430 |
|
|
2022
Q2 | $771K | Sell |
10,315
-1,893
| -16% | -$141K | 0.02% | 535 |
|
|
2022
Q1 | $954K | Buy |
12,208
+2,605
| +27% | +$204K | 0.01% | 636 |
|
|
2021
Q4 | $865K | Sell |
9,603
-5,540
| -37% | -$499K | 0.02% | 404 |
|
|
2021
Q3 | $1.4M | Buy |
15,143
+12,390
| +450% | +$1.15M | 0.03% | 345 |
|
|
2021
Q2 | $214K | Buy |
+2,753
| New | +$214K | 0.01% | 778 |
|